Edge Rewrite
// HTMLRewriter · presentation

This page was redesigned at the edge.

Cloudflare fetched the original article and streamed it through HTMLRewriter to apply an entirely new visual system without rebuilding the source page.

// request.cf · coarse context

A page that knows where it met you.

Only coarse request metadata is shown. This demo does not display or persist visitor IP addresses.

Country
US
Cloudflare location
CMH
Connection
HTTP/2
Language
Not provided

Ray ID: a23f2b71df436019

Jump to content

Talk:Hypertriglyceridemia

Page contents not supported in other languages.
Add topic
From Wikipedia, the free encyclopedia
Latest comment: 11 years ago by Jfdwolff in topic Endocrine Rev

Omega 3

[edit]

I also found this paper interesting Omega-3 fatty acid supplementation accelerates chylomicron triglyceride clearance — Preceding unsigned comment added by [[User:{{{1}}}|{{{1}}}]] ([[User talk:{{{1}}}|talk]] • [[Special:Contributions/{{{1}}}|contribs]])

True, but contradicted by some other sources. JFW | T@lk 12:49, 16 September 2012 (UTC)Reply

Exercise

[edit]

It would be good, if reliable citations are available, to say in the article whatever is known about whether exercise is helpful in treating this condition. If nothing for sure is known either way,I say it would be of value to say that, at least.--Richard L. Peterson71.198.176.141 (talk) 06:12, 14 September 2009 (UTC)Reply

I might be able to add something on the basis of the new guideline, but in the absence of data from there we should limit ourselves to WP:MEDRS-compatible secondary sources. JFW | T@lk 12:49, 16 September 2012 (UTC)Reply

Review

[edit]

In addition to the new Endocrine Society guideline, perhaps this review might be useful: doi:10.1503/cmaj.060963 JFW | T@lk 15:19, 12 September 2012 (UTC)Reply

Another one about pancreatitis, but I can't retrieve the article: doi:10.1097/MOL.0b013e3283319a1d. JFW | T@lk 23:00, 13 September 2012 (UTC)Reply

Atherosclerosis

[edit]

I have removed the following, because it is likely to be conflicting with the CPG paper, or at least will need recalibration:

Wondering how to approach this. JFW | T@lk 12:49, 16 September 2012 (UTC)Reply

References

  1. Le NA, Walter MF. The role of hypertriglyceridemia in atherosclerosis. Curr Atheroscler Rep 2007; 9:110-5.
  2. Stalenhoef AF, de Graaf J. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL. Curr Opin Lipidol 2008; 19:355-61.
  3. Sniderman A, Couture P, de Graaf J. Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. Nat Rev Endocrinol 2010; 6:335-46.

European Atherosclerosis Society Consensus Panel

[edit]

doi:10.1016/S2213-8587(13)70191-8 in Lancet Diab Endocrinol. JFW | T@lk 10:53, 27 December 2013 (UTC)Reply

Endocrine Rev

[edit]

doi:10.1210/er.2014-1062 Genomic approach. JFW | T@lk 23:40, 31 January 2015 (UTC)Reply